S'abonner

Connection

CGRP monoclonal antibodies : summary and effectiveness - Migraine

CGRP monoclonal antibodies : summary and effectiveness - Migraine

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor, Neurological Research and Practice

Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison

What Are CGRP Inhibitors – Migraine Medication

CGRP monoclonal antibodies : summary and effectiveness - Migraine Canada™

CGRP as the target of new migraine therapies — successful translation from bench to clinic

Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials - Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul, 2023

Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study

Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis, The Journal of Headache and Pain

Aimovig (erenumab) for the Treatment of Episodic Migraine